Eva Dombi Selected Research

Eva Dombi Research Topics

Disease

31	Neoplasms (Cancer) 11/2022 - 12/2010
21	Plexiform Neurofibroma 11/2022 - 05/2007
18	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2022 - 05/2007
13	Neurofibroma 11/2020 - 08/2008
10	Neurofibromatoses (Neurofibromatosis) 01/2021 - 01/2013
8	Neurofibrosarcoma (MPNST) 11/2020 - 08/2008
4	Pain (Aches) 01/2021 - 09/2015
3	Nausea 01/2020 - 12/2010
3	Thyroid Neoplasms (Thyroid Cancer) 01/2018 - 02/2012
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2014
2	Fatigue 01/2021 - 12/2010
2	Exanthema (Rash) 01/2020 - 12/2016
2	Vomiting 01/2020 - 09/2014
2	Disease Progression 01/2020 - 01/2019
2	Schwannomatosis 08/2016 - 03/2014
1	Cancer Pain 11/2022
1	Chordoma 01/2021
1	Hypothyroidism 01/2021
1	Human Influenza (Influenza) 01/2021
1	Pseudarthrosis (Pseudoarthrosis) 01/2021
1	Giant Cell Tumor of Tendon Sheath 12/2020
1	Leukemia 12/2020
1	Paronychia 01/2020
1	Congenital Abnormalities (Deformity) 01/2020
1	Diarrhea 01/2020
1	Alveolar Soft Part Sarcoma 12/2019
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2019
1	Proteus Syndrome 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Hearing Loss (Hearing Impairment) 10/2016
1	Hypertension (High Blood Pressure) 10/2016
1	Thrombocytopenic Purpura (Thrombopenic Purpura) 10/2016
1	Acoustic Neuroma (Acoustic Neurinoma) 10/2016
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 08/2016
1	Carcinogenesis 03/2016
1	Idiopathic Pulmonary Fibrosis 09/2014

Drug/Important Bio-Agent (IBA)

9	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2022 - 01/2013
6	AZD 6244IBA 11/2022 - 12/2016
3	mirdametinibIBA 01/2021 - 01/2013
3	vandetanib (ZD6474)IBA 11/2019 - 08/2013
2	CytokinesIBA 01/2021 - 01/2019
2	pexidartinibIBA 12/2020 - 01/2013
2	Phosphotransferases (Kinase)IBA 12/2020 - 01/2013
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020 - 12/2016
2	cediranib (AZD2171)IBA 12/2019 - 12/2010
2	Atrial Natriuretic Factor (ANF)IBA 01/2019 - 01/2018
2	Everolimus FDA Link 01/2019 - 02/2012
2	Bevacizumab (Avastin)FDA Link 01/2019 - 10/2016
2	Neurofibromin 1 (Neurofibromin)IBA 01/2018 - 06/2014
2	Biomarkers (Surrogate Marker)IBA 10/2016 - 11/2013
2	Pharmaceutical PreparationsIBA 10/2015 - 02/2012
2	Sirolimus (Rapamycin)FDA Link 04/2015 - 06/2014
2	pirfenidoneIBA 09/2014 - 05/2007
2	Sorafenib (BAY 43-9006)FDA Link 03/2013 - 02/2012
1	cabozantinibIBA 01/2021
1	AntigensIBA 01/2021
1	Biological ProductsIBA 01/2021
1	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 01/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021
1	VaccinesIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Peptide Nucleic AcidsIBA 01/2021
1	Brachyury protein (Brachyury)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 12/2020
1	Macrophage Colony-Stimulating FactorIBA 12/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2020
1	diphosphoric acid (pyrophosphoric acid)IBA 11/2020
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 11/2019
1	Chemokine CXCL10IBA 02/2019
1	CXCR3 ReceptorsIBA 02/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	MiransertibIBA 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2019
1	Myelin ProteinsIBA 01/2019
1	FLLL 32IBA 01/2019
1	Core Binding Factors (Core-Binding Factor)IBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Ifosfamide FDA LinkGeneric 01/2017
1	peginterferon alfa-2b (Pegintron)FDA Link 01/2017
1	Mitogen-Activated Protein KinasesIBA 12/2016
1	Vascular Endothelial Growth Factor DIBA 10/2016
1	Uvitex SWN (SWN)IBA 08/2016
1	CateninsIBA 03/2016
1	Histones (Histone)IBA 03/2016
1	ras GTPase-Activating Proteins (ras-GAP)IBA 10/2015
1	Guanosine Triphosphate (GTP)IBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	CollagenIBA 09/2014
1	Farnesyltranstransferase (Farnesyltransferase)IBA 05/2014
1	tipifarnib (R115777)IBA 05/2014

Therapy/Procedure

16	Therapeutics 11/2022 - 02/2012
3	Transplantation 11/2020 - 03/2016
3	Drug Therapy (Chemotherapy) 11/2019 - 01/2017
2	Operative Surgical Procedures 01/2021 - 10/2019
2	Radiotherapy 11/2019 - 01/2014
1	Drug Tapering 01/2021
1	Intravenous Administration 01/2021
1	Neoadjuvant Therapy 01/2017
1	Subcutaneous Injections 01/2017